Septerna, Inc. (NASDAQ:SEPN – Get Free Report)’s share price passed below its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $40.62 and traded as low as $39.28. Septerna shares last traded at $40.02, with a volume of 271,755 shares trading hands.
Analyst Upgrades and Downgrades
SEPN has been the subject of several recent analyst reports. Stifel Nicolaus raised their target price on Septerna from $49.00 to $60.00 and gave the stock a “buy” rating in a research note on Tuesday, November 10th. Wall Street Zen lowered Septerna from a “hold” rating to a “sell” rating in a research note on Saturday. HC Wainwright increased their price target on Septerna from $40.00 to $60.00 and gave the stock a “buy” rating in a report on Wednesday, August 12th. JonesTrading increased their price target on Septerna from $43.00 to $62.00 and gave the stock a “buy” rating in a report on Thursday, August 13th. Finally, Raymond James Financial reaffirmed a “strong-buy” rating and set a $49.00 price objective on shares of Septerna in a research report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $56.44.
Check Out Our Latest Analysis on SEPN
Septerna Stock Performance
The business has a fifty day moving average of $40.62 and a 200-day moving average of $33.29. The company has a market capitalization of $1.90 billion, a P/E ratio of -31.02 and a beta of 2.20.
Septerna (NASDAQ:SEPN – Get Free Report) last announced its quarterly earnings results on Monday, November 9th. The company reported ($0.57) EPS for the quarter, missing analysts’ consensus estimates of ($0.42) by ($0.15). Septerna had a negative net margin of 61.29% and a negative return on equity of 14.98%. The business had revenue of $18.88 million for the quarter, compared to the consensus estimate of $20.78 million. Sell-side analysts anticipate that Septerna, Inc. will post -1.45 EPS for the current year.
Insider Activity
In other news, SVP Daniel Long sold 3,333 shares of Septerna stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $37.83, for a total transaction of $126,087.39. Following the completion of the transaction, the senior vice president directly owned 96,412 shares in the company, valued at $3,647,265.96. This trade represents a 3.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Alan Ezekowitz sold 81,820 shares of the business’s stock in a transaction dated Wednesday, November 11th. The stock was sold at an average price of $48.09, for a total transaction of $3,934,723.80. Following the sale, the director directly owned 35,600 shares of the company’s stock, valued at approximately $1,712,004. The trade was a 69.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 89,153 shares of company stock worth $4,210,451 over the last three months. 5.80% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Septerna
A number of hedge funds have recently added to or reduced their stakes in the stock. Covestor Ltd boosted its holdings in Septerna by 19.0% during the third quarter. Covestor Ltd now owns 2,526 shares of the company’s stock worth $98,000 after purchasing an additional 403 shares during the last quarter. Sterling Capital Management LLC increased its stake in Septerna by 215.0% in the 3rd quarter. Sterling Capital Management LLC now owns 630 shares of the company’s stock valued at $25,000 after buying an additional 430 shares during the last quarter. Engineers Gate Manager LP increased its stake in Septerna by 5.0% in the 2nd quarter. Engineers Gate Manager LP now owns 17,350 shares of the company’s stock valued at $581,000 after buying an additional 822 shares during the last quarter. China Universal Asset Management Co. Ltd. lifted its position in shares of Septerna by 12.5% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 12,117 shares of the company’s stock worth $474,000 after buying an additional 1,343 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Septerna during the 3rd quarter worth approximately $93,000.
About Septerna
Septerna is a clinical-stage biotechnology company developing medicines that target G protein-coupled receptors (GPCRs), a large family of proteins involved in many biological processes. The company is based in South San Francisco, California. Its discovery platform is designed to identify drug candidates that act on GPCRs, including targets that have been difficult to address with conventional drug-development approaches. Septerna is advancing candidates for endocrine, metabolic and other disease areas, with an emphasis on small-molecule medicines.
Further Reading
- Five stocks we like better than Septerna
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Septerna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Septerna and related companies with MarketBeat.com's FREE daily email newsletter.
